LAB
insider transactionsSTANDARD BIOTOOLS INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·F
SVP & Chief Business Officer
$25.7K
25.7K sh · $1.00
Own -2%
-
Other·F
Hanjoon Alex Kim KEY
Chief Financial Officer
$18.9K
18.9K sh · $1.00
Own -1%
-
Other·F
Michael Egholm KEY
President & CEO
$97.6K
97.6K sh · $1.00
Own -1%
-
Exercise·M
Hanjoon Alex Kim KEY
Chief Financial Officer
$0
70.2K sh
Own New
-
Other·F
Hanjoon Alex Kim KEY
Chief Financial Officer
$19.3K
21.3K sh · $0.91
Own -1%
-
Exercise·M
Hanjoon Alex Kim KEY
Chief Financial Officer
$0
70.2K sh
Own +3%
-
Exercise·M
Michael Egholm KEY
President & CEO
$0
196.5K sh
Own New
-
Other·F
Michael Egholm KEY
President & CEO
$86.3K
95.0K sh · $0.91
Own -1%
-
Exercise·M
Michael Egholm KEY
President & CEO
$0
196.5K sh
Own +3%
-
Grant·A
SVP & Chief Business Officer
$0
612.2K sh
Own New
-
Grant·A
SVP & Chief Business Officer
$0
272.1K sh
Own +36%
-
Grant·A
Hanjoon Alex Kim KEY
Chief Financial Officer
$0
727.1K sh
Own New
-
Grant·A
Hanjoon Alex Kim KEY
Chief Financial Officer
$0
323.2K sh
Own +13%
-
Grant·A
Michael Egholm KEY
President & CEO
$0
2.3M sh
Own New
-
Grant·A
Michael Egholm KEY
President & CEO
$0
1.0M sh
Own +19%
-
Grant·A
Director
$67.0K
57.3K sh · $1.17
Own +18%
-
Grant·A
Director, 10% Owner
$62.0K
53.0K sh · $1.17
Own +2%
-
Grant·A
Director
$60.0K
51.3K sh · $1.17
Own +26%
-
Other·F
SVP & Chief Business Officer
$22.6K
19.7K sh · $1.15
Own -3%
-
Other·F
Hanjoon Alex Kim KEY
Chief Financial Officer
$14.7K
12.7K sh · $1.15
Own -1%
-
Other·F
Michael Egholm KEY
President & CEO
$76.0K
66.1K sh · $1.15
Own -1%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 20, 2026 | Sean Mackay | Other F | 25.7K | $25.7K |
| May 20, 2026 | Hanjoon Alex Kim KEY | Other F | 18.9K | $18.9K |
| May 20, 2026 | Michael Egholm KEY | Other F | 97.6K | $97.6K |
| Apr 6, 2026 | Hanjoon Alex Kim KEY | Exercise M | 70.2K | $0 |
| Apr 6, 2026 | Hanjoon Alex Kim KEY | Other F | 21.3K | $19.3K |
| Apr 6, 2026 | Hanjoon Alex Kim KEY | Exercise M | 70.2K | $0 |
| Apr 6, 2026 | Michael Egholm KEY | Exercise M | 196.5K | $0 |
| Apr 6, 2026 | Michael Egholm KEY | Other F | 95.0K | $86.3K |
| Apr 6, 2026 | Michael Egholm KEY | Exercise M | 196.5K | $0 |
| Mar 20, 2026 | Sean Mackay | Grant A | 612.2K | $0 |
| Mar 20, 2026 | Sean Mackay | Grant A | 272.1K | $0 |
| Mar 20, 2026 | Hanjoon Alex Kim KEY | Grant A | 727.1K | $0 |
| Mar 20, 2026 | Hanjoon Alex Kim KEY | Grant A | 323.2K | $0 |
| Mar 20, 2026 | Michael Egholm KEY | Grant A | 2.3M | $0 |
| Mar 20, 2026 | Michael Egholm KEY | Grant A | 1.0M | $0 |
| Feb 26, 2026 | Troy Cox | Grant A | 57.3K | $67.0K |
| Feb 26, 2026 | Eli Casdin | Grant A | 53.0K | $62.0K |
| Feb 26, 2026 | Thomas D. Carey | Grant A | 51.3K | $60.0K |
| Feb 23, 2026 | Sean Mackay | Other F | 19.7K | $22.6K |
| Feb 23, 2026 | Hanjoon Alex Kim KEY | Other F | 12.7K | $14.7K |
| Feb 23, 2026 | Michael Egholm KEY | Other F | 66.1K | $76.0K |
About LAB insider trading
This page tracks insider transactions for STANDARD BIOTOOLS INC. (LAB) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.